28 completed, 7 unknown, 3 recruiting, 3 withdrawn. 24 Not applicable, 9 Phase 3, 6 Phase 4, 1 Phase 1.
Follow Immunization: new trials by email Literature Review of Immunization trials Research Report on Immunization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of a Combination SARS-CoV-2 Recombinant Spike and High-Dose Inactivated Influenza Vaccine With Matrix-M Adjuvant in Adult Participants 60 Years of Age and Older IIV-HD (standalone), NVXC19 (EU licensed, standalone), IIV-HD + NVXC19 combination - Immunization, Healthy Volunteers | Phase 3 | Not yet recruiting | Sanofi | 6000 | 2026-11-09 | 2026-10-22 |
| Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe. Efluelda Tetra Pre-filled syringe - Immunization, Influenza (Healthy Volunteers) | Not yet recruiting | Sanofi | 670 | 2026-10-01 | 2025-12-15 | |
| The Dreamy Jet Study Ketamine - Sedation, Blood Drawing Procedure | Phase 1 | Withdrawn | University of Wisconsin, Madison | 2025-09-01 | 2025-08-12 | |
| Description of the Immune Response to Yellow Fever Vaccination blood samples collection - Immunization, Infections | Not applicable | Recruiting | Institut Pasteur | 38 | 2024-09-30 | 2025-06-29 |
| Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) 9-valent HPV vaccine, 2 doses alternate timing, 9-valent HPV vaccine, 3 doses standard timing - Immunization, HPV Infection | Phase 4 | Recruiting | The University of Texas Medical Branch, Galveston | 618 | 2023-01-18 | 2026-09-15 |
| The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle The STOP-HPV Trial 5: Bundle Intervention - Immunization, Vaccination | Not applicable | Unknown | University of California, Los Angeles | 24 | 2022-01-12 | 2022-07-05 |
| Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress Exercise - Immunization | Not applicable | Unknown | Iowa State University | 80 | 2021-03-01 | 2023-08-24 |
| Pediatric Vaccinations Text messaging - Pediatric ALL, Vaccination | Completed | NYU Langone Health | 1034 | 2021-02-09 | 2026-05-14 | |
| Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform Mobile app - CanImmunize, Web based notification - Mobile Apps, Immunization | Not applicable | Completed | The Ottawa Hospital | 2408 | 2020-10-01 | 2023-04-03 |
| HPV Vaccination Study in Postpartum Women Gardasil9 - HPV, Immunization | Phase 4 | Completed | Johns Hopkins University | 225 | 2020-08-03 | 2023-08-29 |
| FluPRINT Study: Characterisation of the Immune and Transcriptional Response to LAIV Fluenz Tetra nasal spray suspension - Immunization | Not applicable | Completed | University of Oxford | 33 | 2019-10-16 | 2022-06-30 |
| GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose 9-valent HPV vaccine, 2 dose efficacy, 9-valent HPV vaccine, 3 doses standard timing - Immunization, Efficacy | Phase 4 | Completed | The University of Texas Medical Branch, Galveston | 767 | 2019-06-17 | 2026-04-16 |
| Assessing Barriers and Increasing Use of Immunization Registries in Pharmacies Immunization Registry Training, Informational flyer - Immunization | Not applicable | Completed | Auburn University | 52 | 2019-01-10 | 2019-10-30 |
| Immunization Schedule Alert Platform ISAP SMS - Immunization | Not applicable | Unknown | Lifespan Healthcare Resource Limited | 1800 | 2018-11-01 | 2018-10-15 |
| The STOP-HPV Trial 3: Prompts Intervention STOP-HPV prompts intervention - Immunization, Vaccination | Not applicable | Unknown | University of California, Los Angeles | 48 | 2018-08-07 | 2022-01-12 |
| The STOP-HPV Trial 4: Bundle Intervention STOP-HPV bundle intervention - Immunization, Vaccination | Not applicable | Unknown | University of California, Los Angeles | 48 | 2018-08-07 | 2020-12-11 |
| The STOP-HPV Trial 6: Single Arm Evaluation of the Maintenance of the STOP-HPV Bundle The STOP-HPV Trial 6: Maintenance - Vaccination, Immunization | Not applicable | Withdrawn | University of California, Los Angeles | 2018-08-07 | 2023-01-27 | |
| The STOP-HPV Trial 2: Performance Feedback Intervention STOP-HPV performance feedback intervention - Immunization, Vaccination | Not applicable | Completed | University of California, Los Angeles | 48 | 2018-08-07 | 2020-04-30 |
| The STOP-HPV Trial 1: Communication Intervention STOP-HPV communication intervention - Immunization, Vaccination | Not applicable | Completed | University of California, Los Angeles | 48 | 2018-08-07 | 2024-07-12 |
| mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations (D0271) Reminders, Conditional financial transfers - Immunization | Not applicable | Completed | Duke University | 412 | 2017-08-15 | 2025-03-07 |
Showing 20 of 43. Sign in to see all of them.
Influenza, Human (5) · Agnosia (3) · Common Cold (2) · Hepatitis B (2) · Abdominal Neoplasms (1) · Abdominal Pain (1) · Behavior (1) · Constipation (1) · Dyspepsia (1) · Flatulence (1) · Haemophilus Infections (1) · Hematologic Diseases (1) · Infections (1) · Leukemia, Myeloid, Acute (1) · Meningitis (1)
Infections (10) · Virus Diseases (8) · Respiratory Tract Diseases (6) · Respiratory Tract Infections (6) · Orthomyxoviridae Infections (5) · Pathological Conditions, Signs and Symptoms (5) · RNA Virus Infections (5) · Nervous System Diseases (4) · Neurologic Manifestations (4) · Signs and Symptoms (4) · Communicable Diseases (3) · DNA Virus Infections (3) · Neoplasms (3) · Neurobehavioral Manifestations (3) · Perceptual Disorders (3)
Influenza Vaccines (2) · 10-valent pneumococcal conjugate vaccine (1) · 13-valent pneumococcal vaccine (1) · Boostrix (1) · Exercise (1) · HibTITER protein, Haemophilus influenzae (1) · Ketamine (1) · Lactoferrin (1) · Meningococcal Vaccines (1) · Music Therapy (1) · PHiD-CV vaccine (1) · Platelet Transfusion (1) · Restraint, Physical (1) · Saline Solution (1) · Vaccines, Combined (1)
University of California, Los Angeles (6) · University of Toronto (3) · Inner Mongolia Yili Industrial Group Co., Ltd (2) · Johns Hopkins University (2) · Pfizer (2) · Public Health England (2) · Sanofi (2) · The University of Texas Medical Branch, Galveston (2) · University of Colorado, Denver (2) · Auburn University (1) · Boston Children's Hospital (1) · CAMC Health System (1) · Children's Hospital of Philadelphia (1) · Children's National Research Institute (1) · Duke University (1)
United States (20) · Canada (4) · United Kingdom (3) · China (2) · France (2) · Japan (2) · Nigeria (2) · Poland (1) · South Korea (1) · Spain (1) · Tanzania (1)
Peter Szilagyi, MD (5) · Abbey B Berenson, MD, PhD (2) · Anna Taddio, PhD (2) · Ying An, Ph.D (2) · Allison Kempe, MD (1) · Allison Kempe, MD, MPH (1) · Amanda Dayton, MA (1) · Amy Grimshaw, MS, MSW (1) · Andrew Pollard, FRCPCH (1) · Andrew Steenhoff, MBBCh (1) · Anne McCarthy (1) · Betty Chou, MD (1) · Chailee Moss, MD (1) · Charles Schiffer (1)
PMID 41276263, PMID 22908112, PMID 23237154, PMID 24533515, PMID 24634424, PMID 25002671, PMID 25780077, PMID 27244859, PMID 27265451, PMID 27902652, PMID 29459064, PMID 31139442, PMID 31272487, PMID 32813276, PMID 33846054, PMID 34028494, PMID 35292212, PMID 36205071, PMID 36814594, PMID 37155240, PMID 38285445, PMID 38320488
R01CA202261 (6), 1RC1LM010513-01 (1), 2009 (1), R01CA187707 (1), R21TW010262 (1), U01HL042824 (1)